#PROTECT has really good long-term randomized survival data for RP vs RT vs active monitor’s (= AS-light)

That’s why these are the standards for favourable risk

There are +++ RCTs of different RT regimens and ADT dur’n for unfav risk. Ablative Rx should be tested in non-inf RCT
#PROTECT